British Columbia Investment Management’s Celgene Corp CELG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q4
Sell
-209,178
Closed -$20.8M 847
2019
Q3
$20.8M Sell
209,178
-40,673
-16% -$3.86M 0.2% 113
2019
Q2
$23.1M Buy
249,851
+4,657
+2% +$442K 0.2% 114
2019
Q1
$23.1M Sell
245,194
-97,107
-28% -$8.49M 0.21% 113
2018
Q4
$21.9M Buy
342,301
+92,209
+37% +$6.81M 0.2% 119
2018
Q3
$22.4M Sell
250,092
-79,861
-24% -$7.06M 0.24% 96
2018
Q2
$26.2M Sell
329,953
-92,721
-22% -$7.7M 0.23% 103
2018
Q1
$37.7M Sell
422,674
-145,723
-26% -$14M 0.29% 75
2017
Q4
$59.3M Buy
568,397
+39,066
+7% +$4.41M 0.42% 52
2017
Q3
$77.2M Sell
529,331
-661
-0.1% -$90K 0.6% 35
2017
Q2
$68.8M Sell
529,992
-2,418
-0.5% -$296K 0.55% 40
2017
Q1
$66.2M Buy
532,410
+49,975
+10% +$5.98M 0.53% 39
2016
Q4
$55.8M Buy
482,435
+47,095
+11% +$5.24M 0.49% 46
2016
Q3
$45.5M Sell
435,340
-62,706
-13% -$6.79M 0.46% 48
2016
Q2
$49.1M Buy
498,046
+3,835
+0.8% +$397K 0.43% 47
2016
Q1
$49.5M Buy
494,211
+23,267
+5% +$2.4M 0.47% 47
2015
Q4
$56.4M Sell
470,944
-7,299
-2% -$844K 0.54% 43
2015
Q3
$51.7M Sell
478,243
-4,879
-1% -$605K 0.53% 44
2015
Q2
$55.9M Buy
483,122
+93,600
+24% +$10.7M 0.53% 41
2015
Q1
$44.9M Sell
389,522
-30,068
-7% -$3.59M 0.41% 54
2014
Q4
$46.9M Sell
419,590
-20,998
-5% -$2.21M 0.39% 58
2014
Q3
$41.8M Sell
440,588
-35,316
-7% -$3.19M 0.35% 68
2014
Q2
$40.9M Buy
475,904
+10,996
+2% +$836K 0.33% 75
2014
Q1
$32.5M Sell
464,908
-38,328
-8% -$3.04M 0.27% 92
2013
Q4
$42.5M Sell
503,236
-41,396
-8% -$3.28M 0.34% 74
2013
Q3
$42M Sell
544,632
-42,522
-7% -$2.98M 0.35% 71
2013
Q2
$34.3M Buy
+587,154
New +$35.3M 0.28% 88

Other funds holding CELG

British Columbia Investment Management's CELG Position: Q4 2019 in Review

British Columbia Investment Management sold out of Celgene Corp (CELG) in Q4 2019, closing a stake of 209,178 shares — an estimated $20.8M sold.

British Columbia Investment Management first reported a position in CELG in Q2 2013 and held it in 26 quarters. The position peaked at $77.2M in Q3 2017. 4 funds tracked by Wall St. Rank hold CELG as of Q4 2019.

  • British Columbia Investment Management reported no remaining Celgene Corp position as of Q4 2019 after selling out during the quarter.
  • British Columbia Investment Management sold 209,178 Celgene Corp shares in Q4 2019, an estimated $20.8M.
  • British Columbia Investment Management first reported a position in Celgene Corp in Q2 2013 and held it in 26 quarters.
  • British Columbia Investment Management's Celgene Corp position peaked at $77.2M in Q3 2017.
  • 4 funds tracked by Wall St. Rank held Celgene Corp as of Q4 2019.

Based on British Columbia Investment Management's 13F filing for Q4 2019, filed 12 Feb 2020.